Campion O, Thevenard Devy J, Billottet C, Schneider C, Etique N, Dupuy JW, Raymond AA, Boulagnon Rombi C, Meunier M, Djermoune EH, Lelièvre E, Wahart A, Bour C, Hachet C, Cairo S, Bikfalvi A, Dedieu S, Devy J

Biomedicines. 2021 Oct 9;9(10):

The detrimental invasiveness of glioma cells controlled by gadolinium chelate-coated gold nanoparticles.

Durand M, Lelievre E, Chateau A, Berquand A, Laurent G, Carl P, Roux S, Chazee L, Bazzi R, Eghiaian F, Jubreaux J, Ronde P, Barberi-Heyob M, Chastagner P, Devy J, Pinel S

Nanoscale. 2021 May 12;:

Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted on Melanoma.

Fuselier C, Quemener S, Dufay E, Bour C, Boulagnon-Rombi C, Bouland N, Djermoune EH, Devy J, Martiny L, Schneider C

Front Oncol. 2021 ;11:597503

Multimodal Approach for Cancer Cell Investigation.

Berquand A, Devy J

Methods Mol Biol. 2021 ;2350:289-297

Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV.

Vautrin-Glabik A, Devy J, Bour C, Baud S, Choulier L, Hoarau A, Dupont-Deshorgue A, Sellier C, Brassart B, Oudart JB, Ramont L, Monboisse JC, Brassart-Pasco S

Front Cell Dev Biol. 2020 ;8:775

Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression.

Campion O, Al Khalifa T, Langlois B, Thevenard-Devy J, Salesse S, Savary K, Schneider C, Etique N, Dedieu S, Devy J

Front Oncol. 2020 ;10:882

Fluorescent Radiosensitizing Gold Nanoparticles.

Jiménez Sánchez G, Maury P, Stefancikova L, Campion O, Laurent G, Chateau A, Bouraleh Hoch F, Boschetti F, Denat F, Pinel S, Devy J, Porcel E, Lacombe S, Bazzi R, Roux S

Int J Mol Sci. 2019 Sep 18;20(18):

A gentle approach to investigate the influence of LRP-1 silencing on the migratory behavior of breast cancer cells by atomic force microscopy and dynamic cell studies.

Berquand A, Meunier M, Devy JT, Ivaldi C, Campion O, Dedieu S, Molinari M, Devy J

Nanomedicine. 2018 Nov 9;:

Quantitative characterization of single-cell adhesion properties by atomic force microscopy using protein-functionalized microbeads.

Chièze L, Le Cigne A, Meunier M, Berquand A, Dedieu S, Devy J, Molinari M

J. Mol. Recognit.. 2018 Nov 7;:e2767

New photodynamic molecular beacons (PMB) as potential cancer-targeted agents in PDT.

Stallivieri A, Colombeau L, Devy J, Etique N, Chaintreuil C, Myrzakhmetov B, Achard M, Baros F, Arnoux P, Vanderesse R, Frochot C

Bioorg. Med. Chem.. 2018 02 1;26(3):688-702

Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells.

Theret L, Jeanne A, Langlois B, Hachet C, David M, Khrestchatisky M, Devy J, Hervé E, Almagro S, Dedieu S

Oncotarget. 2017 Oct 3;8(45):78614-78632

Intrinsic dynamics study identifies two amino acids of TIMP-1 critical for its LRP-1-mediated endocytosis in neurons.

Verzeaux L, Belloy N, Thevenard-Devy J, Devy J, Ferracci G, Martiny L, Dedieu S, Dauchez M, Emonard H, Etique N, Devarenne-Charpentier E

Sci Rep. 2017 Jul;7(1):5375

Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.

Jeanne A, Boulagnon-Rombi C, Devy J, Théret L, Fichel C, Bouland N, Diebold MD, Martiny L, Schneider C, Dedieu S

Clin. Exp. Metastasis. 2016 Oct;33(7):637-49

Analysis of the effect of LRP-1 silencing on the invasive potential of cancer cells by nanomechanical probing and adhesion force measurements using atomic force microscopy.

Le Cigne A, Chièze L, Beaussart A, El-Kirat-Chatel S, Dufrêne YF, Dedieu S, Schneider C, Martiny L, Devy J, Molinari M

Nanoscale. 2016 Apr;8(13):7144-54

Cellular Cholesterol Distribution Influences Proteolytic Release of the LRP-1 Ectodomain.

Dekky B, Wahart A, Sartelet H, Féré M, Angiboust JF, Dedieu S, Piot O, Devy J, Emonard H

Front Pharmacol. 2016 ;7:25

Identification of TAX2 peptide as a new unpredicted anti-cancer agent.

Jeanne A, Sick E, Devy J, Floquet N, Belloy N, Theret L, Boulagnon-Rombi C, Diebold MD, Dauchez M, Martiny L, Schneider C, Dedieu S

Oncotarget. 2015 May 22.

Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.

Goury A, Meghraoui-Kheddar A, Belmokhtar K, Vuiblet V, Ortillon J, Jaisson S, Devy J, Le Naour R, Tabary T, Cohen JH, Schmidt AM, Rieu P, Toure F

J Immunol. 2015 Apr 15;194(8):3612-22

Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent.

Ouchani F, Jeanne A, Thevenard J, Helesbeux JJ, Wahart A, Letinois I, Duval O, Martiny L, Charpentier E, Devy J

Invest New Drugs. 2015 Feb;33(1):75-85

Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities.

Thevenard J, Verzeaux L, Devy J, Etique N, Jeanne A, Schneider C, Hachet C, Ferracci G, David M, Martiny L, Charpentier E, Khrestchatisky M, Rivera S, Dedieu S, Emonard H

PLoS ONE. 2014 ;9(7):e103839

LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.

Perrot G, Langlois B, Devy J, Jeanne A, Verzeaux L, Almagro S, Sartelet H, Hachet C, Schneider C, Sick E, David M, Khrestchatisky M, Emonard H, Martiny L, Dedieu S

Mol Cell Biol. 2012 Aug;32(16):3293-307

Targeting focal adhesion assembly by ethoxyfagaronine prevents lymphoblastic cell adhesion to fibronectin.

Ouchani F, Devy J, Rusciani A, Helesbeux JJ, Salesse S, Letinois I, Gras-Billart D, Duca L, Duval O, Martiny L, Charpentier E

Anal Cell Pathol (Amst). 2012;35(4):267-84

Tetrastatin, the NC1 domain of the alpha4(IV) collagen chain: a novel potent anti-tumor matrikine.

Brassart-Pasco S, Senechal K, Thevenard J, Ramont L, Devy J, Di Stefano L, Dupont-Deshorgue A, Brezillon S, Feru J, Jazeron JF, Diebold MD, Ricard-Blum S, Maquart FX, Monboisse JC

PLoS One. 2012;7(4):e29587